Learn about the National Emphysema Treatment Trial, a landmark study that clarified the risks and benefits of lung volume reduction surgery to treat emphysema.

The addition of LABA (salmeterol or formoterol) to the treatment of patients who require more than low-dose inhaled corticosteroid (ICS) alone to control asthma improves lung function, …

Oct 25, 2023 · Alpha-1 antitrypsin (AAT) deficiency increases an individual’s risk for COPD. The deficiency is an inherited genetic condition with no cure. The resulting COPD would be treated …

Feb 13, 2024 · COPD is a serious lung disease that includes two main conditions — chronic bronchitis and emphysema.

Oct 8, 2024 · Lung volume reduction surgery: The National Emphysema Treatment Trial (NETT) was the first multicenter trial to study whether a surgical procedure called lung volume …

Oct 4, 2024 · It can detect COPD before symptoms are recognized. Your provider may also use the test results to find out how serious your COPD is and help set your treatment goals. …

Pathogenesis, genetics, treatment, and prevention of COPD, emphysema, and lung disease with alpha-1-antitrypsin deficiency; susceptibility to environmental exposures (smoking, air …

Nov 8, 2024 · COPD is a lung disease that makes it hard to breathe. It includes emphysema and chronic bronchitis. COPD is a major cause of disability and death, but it can often be prevented.

Oct 4, 2024 · Causes and Risk Factors of COPD Learn about NHLBI research to help understand why some people get COPD or get more severe COPD than others.

The National Emphysema Treatment Trial (NETT) was a landmark study that clarified the risks and benefits of lung volume reduction surgery (LVRS) to treat patients whose COPD is mainly …